Inventor · disambiguated record
David Hardick
Also filed as: HARDICK DAVID · HARDICK DAVID J · HARDICK DAVID JAMES
12 granted patents·6 pending applications·10 citations·filing 1999–2025
84Inventor score
Files withSTORM THERAPEUTICS LTD8BLACKTHORN THERAPEUTICS INC2NEUMORA THERAPEUTICS INC2ARES TRADING SA1HOFFMANN LA ROCHE1
Top patents by PatentIndex Score
18 records- 0192US11725010B2Polyheterocyclic compounds as METTL3 inhibitorsSTORM THERAPEUTICS LTD·Filed 2022·Granted Aug 15, 2023·3 cites·3 claims
- 0278US12358915B2METTL3 inhibitory compoundsSTORM THERAPEUTICS LTD·Filed 2020·Granted Jul 15, 2025·1 cites·18 claims
- 0378US2025122195A1Polyheterocyclic compounds as mettl3 inhibitorsSTORM THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 0477US11186577B2Vasopressin receptor antagonists and products and methods related theretoBLACKTHORN THERAPEUTICS INC·Filed 2018·Granted Nov 30, 2021·2 cites·11 claims
- 0575US10538530B2Vasopressin receptor antagonists and products and methods related theretoBLACKTHORN THERAPEUTICS INC·Filed 2018·Granted Jan 21, 2020·1 cites·104 claims
- 0667US11858943B2Vasopressin receptor antagonists and products and methods related theretoNEUMORA THERAPEUTICS INC·Filed 2021·Granted Jan 2, 2024·0 cites·16 claims
- 0766US2025388577A1Mettl3 inhibitory compoundsSTORM THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
- 0864US12195458B2Polyheterocyclic compounds as METTL3 inhibitorsSTORM THERAPEUTICS LTD·Filed 2020·Granted Jan 14, 2025·0 cites·21 claims
- 0959US12152038B2Vasopressin receptor antagonists and products and methods related theretoNEUMORA THERAPEUTICS INC·Filed 2021·Granted Nov 26, 2024·0 cites·123 claims
- 1059US9024033B2Anti-malarial agentsWITTY MICHAEL JOHN·Filed 2011·Granted May 5, 2015·1 cites·10 claims
- 1156US2024279222A1Processes for the preparation of inhibitory compoundsSTORM THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1254US2024101589A1Inhibitors of mettl3STROM THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1353US2023391770A1Mettl3 inhibitory compoundsSTORM THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1450US11541132B2Radiolabeled compoundsHOFFMANN LA ROCHE·Filed 2020·Granted Jan 3, 2023·0 cites·4 claims
- 1548US2022370453A1Bicyclic heterocyclic compounds as inhibitors of bcdin3d activitySTORM THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 1641US9527853B2Fused triazole derivatives as gamma secretase modulatorsARES TRADING SA·Filed 2013·Granted Dec 27, 2016·0 cites·12 claims
- 1729US6197811B1Cytokine production inhibitorsTERRAGEN DISCOVERY INC·Filed 1999·Granted Mar 6, 2001·1 cites·13 claims
- 1827US6518316B1Cytokine production and tyrosine kinase inhibitorsXENOVA LTD·Filed 1999·Granted Feb 11, 2003·1 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when David Hardick files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →